impact factor, citescore
logo
In press
In Press
Recent issue
Recent issue
Recent Supplement
Recent supplement
archives
Archives
articles free
Free to view
Search
Search
 

Diagnosis

 

Determinants of impairment in lung diffusing capacity in patients with systemic sclerosis

1, 2, 3, 4, 5, 6, 7

 

  1. Department of Cardiologic, Thoracic and Vascular Sciences, University of Padova, Padova, Italy.
  2. Rheumatology Unit, Department of Medicine, University of Padova, Padova, Italy.
  3. Department of Cardiologic, Thoracic and Vascular Sciences, University of Padova, Padova, Italy.
  4. Department of Cardiologic, Thoracic and Vascular Sciences, University of Padova, Padova, Italy.
  5. Rheumatology Unit, Department of Medicine, University of Padova, Padova, Italy.
  6. Department of Cardiologic, Thoracic and Vascular Sciences, University of Padova, Padova, Italy. piero.maestrelli@unipd.it
  7. Rheumatology Unit, Department of Medicine, University of Padova, Padova, Italy.

CER7724
2015 Vol.33, N°4 ,Suppl.91
PI 0080, PF 0086
Diagnosis

Free to view
(click on article PDF icon to read the article)

PMID: 25897784 [PubMed]

Received: 08/07/2014
Accepted : 24/11/2014
In Press: 16/04/2015
Published: 31/08/2015

Abstract

OBJECTIVES:
Lung diffusing capacity for carbon monoxide (DLCO) is impaired in interstitial lung disease (ILD) and pulmonary arterial hypertension (PAH) associated to systemic sclerosis (SSc), but the mechanism of DLCO reduction remains controversial. We hypothesised that the determinants of DLCO impairment differ in interstitial or vascular involvement of the lung of SSc patients.
METHODS:
DLCO was partitioned into alveolar-capillary membrane conductance (Dm) and pulmonary capillary blood volume (Vc) using combined single-breath DLNO and DLCO measurements. Seventeen SSc patients without pulmonary involvement (SSc), 20 SSc patients with ILD (SSc-ILD), with and without PAH, and 21 healthy controls were included.
RESULTS:
DLNO and Dm were reduced in SSc patients as compared with controls, whereas Vc was not significantly different. SSc-ILD patients showed a highly significant decrease in Dm and Vc as compared with SSc patients and controls. Vc tended to be more reduced than Dm in SSc-ILD patients with PAH. Dm and Vc were negatively correlated with PAPs and HCRT scores, but the relationship with the HRCT score was stronger.
CONCLUSIONS:
DLNO is more sensitive than DLCO in detecting functional impairment in SSc without radiologic or haemodynamic alterations. A disproportional reduction of Dm relative to Vc suggests a thickening of the blood-gas diffusion barrier in these patients. In SSc patients with detectable ILD, the gas exchange impairment is due to both components of lung diffusing capacity, and partitioning of DLCO in Dm and Vc is of little use in distinguishing the patients with only ILD from those with ILD complicated by PAH.

Rheumatology Article